Evidence map›Paper›PMID 41415214›Full record

ReviewBioinorganic chemistry and applications2025

Inorganic Nanoparticles Containing Plant-Derived Compounds for Kidney Treatment.

Michel Stéphane Heya, David Gilberto García-Hernández, Romario García-Ponce, Donald Fernandes

Abstract readReview
In one paragraph

Review in Bioinorganic chemistry and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michel Stéphane HeyaResearch Center in Nutrition and Public Health, School of Public Health and Nutrition, Autonomous University of Nuevo León, San Nicolás de los Garza, Nuevo León, Mexico, uanl.mx.ORCID https://orcid.org/0000-0002-6886-4724
David Gilberto García-HernándezDepartment of Chemistry, Faculty of Biological Sciences, Autonomous University of Nuevo León, San Nicolás de los Garza, Nuevo León, Mexico, uanl.mx.ORCID https://orcid.org/0000-0001-8409-139X
Romario García-PonceDepartment of Chemistry, Faculty of Biological Sciences, Autonomous University of Nuevo León, San Nicolás de los Garza, Nuevo León, Mexico, uanl.mx.ORCID https://orcid.org/0000-0003-0797-9605
Donald FernandesDepartment of Chemistry and Biology, Toronto Metropolitan University, Toronto, Canada, ryerson.ca.ORCID https://orcid.org/0000-0001-7871-698X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have shown that many kidney diseases are associated with oxidative stress caused by factors such as changes in diet, environmental pollution, and the excessive use of medications, which contribute to cellular damage in the kidneys. This pathology, whose prevalence is increasing, presents a significant challenge for current medicine due to the multiple physiological barriers that limit the effectiveness of conventional treatments. In response to this issue, inorganic nanoparticles synthesized through green methods, using derivatives from medicinal plants as antioxidants (such as flavonoids and polyphenols, among others), have emerged as a promising therapeutic alternative. This approach not only avoids the use of toxic chemical reagents but also allows for the design of nanoparticles with specific physicochemical properties, such as size, charge, and shape, which facilitate their passage through the digestive system, evasion of the immune system, and targeted delivery to renal tissue. The objective of this study is to analyze the potential of inorganic nanoparticles as an innovative therapeutic strategy for the treatment and prevention of kidney diseases, leveraging their ability to protect the kidneys from oxidative damage caused by reactive oxygen species.

Indexed as

antioxidantsinorganic nanoparticlesnephroprotectionoxidative stress

Identifiers

PMID41415214
PMCPMC12709661

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.